RetINal Toxicity And HydroxyChloroquine Therapy (INTACT): protocol for a prospective population-based cohort study

PURPOSE: Hydroxychloroquine (HCQ) is an important medication for patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other rheumatic diseases. Although it is well-tolerated and cost-effective, the risk of HCQ retinal toxicity is of increasing concern. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Daftarian, Narsis, Lima, Adriana, Marozoff, Shelby, Ojo, Dami, Levasseur, Steve D, Maberley, David A L, Hoens, Alison, Esdaile, John, Dawes, Martin, Aviña-Zubieta, J Antonio, Adante, Beatrice, Bhui, Ravinder Dennis, Bhui, Suruchi B, Butler, Michael, Chui, Lica, Erasmus, Murray, Etminan, Mahyar, Godinho, Derek, Hay, Elizabeth, Hollands, Hussein, Hoonjan, Malvinder, Joe, Aaron, Lukaris, Andrew, Mammo, Zaid, Navajas, Eduardo, Pakzad-Vaezi, Kaivon, Sanmugasunderam, Suren, Shojania, Kam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860004/
https://www.ncbi.nlm.nih.gov/pubmed/35177450
http://dx.doi.org/10.1136/bmjopen-2021-053852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860004/
https://www.ncbi.nlm.nih.gov/pubmed/35177450
http://dx.doi.org/10.1136/bmjopen-2021-053852

Ejemplares similares